Cover ImageSALE
市場調查報告書

全球隱形眼鏡市場:2018年∼2022年

Global Contact Lens Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 264454
出版日期 內容資訊 英文 116 Pages
訂單完成後即時交付
價格
Back to Top
全球隱形眼鏡市場:2018年∼2022年 Global Contact Lens Market 2018-2022
出版日期: 2018年04月27日 內容資訊: 英文 116 Pages
簡介

關於隱形眼鏡

隱形眼鏡,是為了矯正視力在眼上直接配戴的薄鏡片,治療目的之外也有審美目的的使用。

Technavio的分析師預測,從2018年到2022年之間全球隱形眼鏡市場將以6.45%的年複合成長率成長。

本報告提供隱形眼鏡的全球市場調查,市場概要,各產品、地區的市場趨勢,市場規模的變化與預測,成長促進因素以及課題分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模的變化與預測

第6章 波特的五力分析

  • 買方議價能力
  • 供給企業談判力
  • 新加入業者的威脅
  • 替代品的威脅
  • 競爭企業間的敵對關係
  • 市場情形

第7章 全球隱形眼鏡市場:各產品

  • 市場區隔:各產品
  • 市場比較:各產品
    • 軟式隱形眼鏡
    • 氧滲透性硬隱形眼鏡
    • 混合隱形眼鏡
  • 市場機會:各產品

第8章 客戶形勢

第9章 地區形勢

  • 市場區隔:各地區
  • 市場比較:各地區
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區
  • 市場機會

第10章 決策架構

第11章 成長要素與課題

  • 市場成長要素
  • 市場課題

第12章 市場趨勢

  • 促進隱形眼鏡安全的使用的配合措施的擴大
  • 技術的進步
  • 彩色隱形眼鏡鏡片的人氣上升

第13章 業者情勢

  • 概要
  • 創造性破壞狀況

第14章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Johnson & Johnson
  • Novartis
  • The The Cooper Companies Companies
  • Valeant Pharmaceuticals
  • ZEISS

第15章 附錄

  • 簡稱的清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR21895

About Contact Lens

Contact lenses are thin lenses placed directly on the surface of the eye to correct the vision. It can be used for therapeutic or aesthetic purposes as well. Contact lenses improve all-around vision, allowing clear peripheral vision. They also eliminate glare and are more comfortable to wear and carry.

Technavio's analysts forecast the global contact lens market to grow at a CAGR of 6.45% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global contact lens market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Contact Lens Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Johnson & Johnson
  • Novartis
  • The Cooper Companies
  • Valeant Pharmaceuticals
  • ZEISS

Market driver

  • Increasing advantages of contact lens over glass lens
  • For a full, detailed list, view our report

Market challenge

  • High cost of products
  • For a full, detailed list, view our report

Market trend

  • Growing initiatives promoting safe usage of contact lens
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Global soft contact lens market
  • Global RGP contact lens market
  • Global hybrid contact lens market
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Growing initiatives promoting safe usage of contact lenses
  • Technological advances
  • Increased preference toward cosmetic contact lens

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Johnson & Johnson
  • Novartis
  • The The Cooper Companies Companies
  • Valeant Pharmaceuticals
  • ZEISS

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global vision care market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global contact lens market 2017-2022 ($ mn)
  • Exhibit 09: Global contact lens market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Product - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Soft contact lens - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Soft lens - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: RGP lens - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: RGP lens - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Hybrid lens - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 25: Hybrid lens - Year-over-year growth 2018-2022 (%)
  • Exhibit 26: Market opportunity by product
  • Exhibit 27: Customer landscape
  • Exhibit 28: Global - Market share by geography 2017-2022 (%)
  • Exhibit 29: Regional comparison
  • Exhibit 30: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 32: Top three countries in Americas
  • Exhibit 33: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 34: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 35: Top three countries in EMEA
  • Exhibit 36: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 37: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 38: Top three countries in APAC
  • Exhibit 39: Market opportunity
  • Exhibit 40: Rise in population aged 65 and above (% of total)
  • Exhibit 41: R&D funding for eye disease and disorders of vision for FY 2013 to FY 2016 ($ millions)
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Johnson & Johnson: Overview
  • Exhibit 48: Johnson & Johnson- Business segments
  • Exhibit 49: Johnson & Johnson - Organizational developments
  • Exhibit 50: Johnson & Johnson - Geographic focus
  • Exhibit 51: Johnson & Johnson - Segment focus
  • Exhibit 52: Johnson & Johnson - Key offerings
  • Exhibit 53: Novartis: Overview
  • Exhibit 54: Novartis- Business segments
  • Exhibit 55: Novartis- Organizational developments
  • Exhibit 56: Novartis- Geographic focus
  • Exhibit 57: Novartis- Segment focus
  • Exhibit 58: Novartis- Key offerings
  • Exhibit 59: The Cooper Companies: Overview
  • Exhibit 60: The Cooper Companies- Business segments
  • Exhibit 61: The Cooper Companies- Organizational developments
  • Exhibit 62: The Cooper Companies- Geographic focus
  • Exhibit 63: The Cooper Companies- Segment focus
  • Exhibit 64: The Cooper Companies- Key offerings
  • Exhibit 65: Valeant Pharmaceuticals: Overview
  • Exhibit 66: Valeant Pharmaceuticals- Business segments
  • Exhibit 67: Valeant Pharmaceuticals- Organizational developments
  • Exhibit 68: Valeant Pharmaceuticals- Geographic focus
  • Exhibit 69: Valeant Pharmaceuticals- Segment focus
  • Exhibit 70: Valeant Pharmaceuticals- Key offerings
  • Exhibit 71: ZEISS: overview
  • Exhibit 72: ZEISS- Business segments
  • Exhibit 73: ZEISS- Organizational developments
  • Exhibit 74: ZEISS- Geographic focus
  • Exhibit 75: ZEISS- Segment focus
  • Exhibit 76: ZEISS - Key offerings
Back to Top